Dr Wise on the Impact of Genetic Testing on Patient Outcomes in Prostate Cancer

David R. Wise, MD, PhD, discusses his presentation from an OncLive® State of the Science Summit™ on prostate cancer, during where he discussed the treatment of patients with metastatic castration-resistant prostate cancer.

Related Keywords

,Department Of Urology ,Department Of Medicine ,Langone Health Perlmutter Cancer Center ,Grossman School Of Medicine ,Langone Health ,Genitourinary Medical Oncology ,Perlmutter Cancer Center ,Science Summit ,Nyu Langone X27s Perlmutter Cancer Center ,Onclive Tv ,Prostate Cancer ,